Kataegis
Kataegis is a phenomenon observed in genomics and cancer research, characterized by a localized hypermutation in the genome. It was first described in 2012 by researchers studying breast cancer genomes. The term "kataegis" is derived from the Greek word for "thunderstorm", reflecting the storm-like nature of the mutations observed.
Overview[edit | edit source]
Kataegis is a pattern of localized hypermutation that occurs in clusters, or "storms", across the genome. These clusters are often found in regions of the genome that are important for cell function, such as genes that control cell growth and division. The mutations in these regions can lead to the development of cancer.
Mechanism[edit | edit source]
The exact mechanism of kataegis is not fully understood. However, it is thought to be associated with the process of DNA replication and repair. During DNA replication, errors can occur that lead to mutations. Normally, these errors are corrected by the cell's DNA repair machinery. However, in kataegis, this repair process appears to be faulty, leading to a buildup of mutations.
One theory is that kataegis is caused by a process called APOBEC-mediated mutagenesis. APOBEC proteins are a family of enzymes that can modify DNA, and they have been implicated in a number of cancers. In this theory, APOBEC proteins are thought to cause the mutations seen in kataegis.
Clinical significance[edit | edit source]
Kataegis has been observed in a number of different cancers, including breast cancer, lung cancer, and colorectal cancer. The presence of kataegis in a tumor can have significant implications for the prognosis and treatment of the cancer. For example, tumors with kataegis may be more resistant to certain types of chemotherapy.
In addition, the study of kataegis can provide insights into the mechanisms of cancer development and progression. Understanding how kataegis occurs could potentially lead to new strategies for preventing or treating cancer.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD